Every material Form 8-K Inter Parfums has filed with the SEC since November 06, 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Interparfums reported third-quarter 2026 net sales of $430 million, flat from a year earlier, and diluted EPS of $2.13, up from $2.05. The company raised its 2026 sales outlook to $1.49 billion from $1.48 billion and kept its 2026 EPS outlook at $4.85, which matters to shareholders because higher sales guidance and rising profit per share point in the same direction.
Q3 2026 net sales were $430 million, flat year over year; diluted EPS was $2.13 versus $2.05.
Nine-month 2026 net sales rose 1% to $1.1 billion, and nine-month diluted EPS rose 2% to $4.43.
2026 sales outlook raised from $1.48 billion to $1.49 billion; 2026 EPS outlook maintained at $4.85.
Initial 2027 guidance will be released on November 18, 2026; the $0.80 quarterly dividend is payable December 31, 2026.
Interparfums reported third-quarter 2026 net sales of $430 million, unchanged from the prior year, and nine-month sales of $1.115 billion, up 1%. European based operations grew 4% in the quarter while United States based operations fell 7%, partly due to about $10 million of delayed giftset shipments that will now be recognized in the fourth quarter. The release covers net sales only; full quarterly results are scheduled for November 4, 2026.
Q3 2026 net sales: $430 million, flat versus $430 million in Q3 2025
Nine-month 2026 net sales: $1.115 billion, up 1% from $1.102 billion
European based net sales rose 4% to $306 million in Q3; United States based net sales fell 7% to $127 million
Full third-quarter and nine-month results due November 4, 2026 after market close; conference call November 5, 2026 at 11:00 am ET
Interparfums reported second-quarter 2026 net sales of $341 million, up 2% from a year earlier, but diluted EPS fell to $0.95 from $0.99 and operating income dropped 17% to $49 million. The company reaffirmed its 2026 outlook of $1.48 billion in sales and EPS of $4.85, and it spent more on advertising and promotion, so shareholders face higher costs against steady top-line growth.
Q2 2026 net sales $341 million (+2%); first-half net sales $686 million (+2%)
Q2 diluted EPS $0.95 vs. $0.99 a year ago; operating margin 14.4% vs. 17.7%
2026 guidance reaffirmed: $1.48 billion in sales and EPS of $4.85
Quarterly dividend of $0.80 per share payable September 30, 2026
Interparfums reported second-quarter 2026 net sales of $341 million, up 2% from $334 million a year earlier, and first-half net sales of $686 million, also up 2%. The gain came from U.S.-based operations, which rose 18%, while European-based sales fell 4%. The release gives sales only; the company said it will report full earnings for the period on August 4, 2026.
Q2 2026 net sales were $341 million versus $334 million in Q2 2025, up 2%.
First-half 2026 net sales were $686 million versus $673 million, up 2%.
U.S.-based net sales rose 18% to $113 million; European-based net sales fell 4% to $231 million.
The company will report earnings for the three and six months ended June 30, 2026 on August 4, 2026, with a conference call on August 5, 2026.
Interparfums reported first-quarter 2026 net sales of $345 million, up 2% from $339 million, and diluted EPS of $1.35 versus $1.32 a year earlier. The company reaffirmed its full-year 2026 outlook of $1.48 billion in sales and EPS of $4.85, and declared a $0.80 quarterly dividend payable June 30, 2026.
Q1 2026 net sales $345 million (up 2%); net income attributable to Interparfums $43 million vs. $42 million
Gross margin 65.1% vs. 63.7%; operating income $74 million vs. $75 million, operating margin 21.5% vs. 22.2%
2026 guidance reaffirmed: $1.48 billion in sales and EPS of $4.85
Quarterly dividend of $0.80 per share payable June 30, 2026, to holders of record June 15, 2026
Interparfums reported first-quarter 2026 net sales of $345 million, up 2% from $339 million, with a positive 4.6% foreign exchange impact. CEO Jean Madar said organic sales declined 2% excluding the Middle East war, and the company reduced its forecast for the Middle East region. Full first-quarter financial results are not included in this filing and will be issued May 5, 2026.
Q1 2026 net sales $345 million vs $339 million in Q1 2025, up 2% on a reported basis
CEO said organic sales declined 2%; the war in the Middle East was an estimated 1% headwind
Company reduced its forecast for the Middle East region but said it remains cautiously optimistic for 2026
Full results for the quarter ended March 31, 2026 due May 5, 2026, with a conference call on May 6, 2026 at 11:00 am ET
Interparfums reported record fourth-quarter and full-year 2025 results, with full-year net sales of $1.49 billion (up 2%) and diluted EPS of $5.24 (up from $5.12). The company reaffirmed its 2026 outlook of $1.48 billion in sales and $4.85 in EPS and kept its annual dividend at $3.20 per share, but said it may revisit guidance later in 2026.
Fourth-quarter 2025 net sales rose 7% to $386 million and diluted EPS rose 16% to $0.88, while operating income fell 24% to $28 million.
Full-year 2025 operating income was $270 million, down 2% from $275 million, with operating margin of 18.2% versus 18.9%.
2026 guidance is $1.48 billion in sales and $4.85 EPS, unchanged; the company will monitor early-2026 developments before potentially revisiting it.
The Board approved a 2026 annual cash dividend of $3.20 per share, unchanged from 2025; the next $0.80 quarterly dividend is payable March 31, 2026.
Interparfums reported fourth-quarter 2025 net sales of $386 million, up 7% from $362 million a year earlier, and full-year net sales of $1.49 billion, up 2%. The release covers net sales only; full financial results, including profit, will be issued on February 24, 2026, so shareholders will not see earnings until then.
Q4 2025 net sales were $386 million, up 7% on a reported basis and 3% on an organic basis.
U.S.-based net sales fell 6% for the full year to $482 million, while European-based net sales rose 7% to $1.02 billion.
Full results will be released February 24, 2026, with a conference call on February 25, 2026 at 11:00 am ET.
Interparfums reported third-quarter 2025 net income attributable to the company of $66 million, or $2.05 per diluted share, up 6% from a year earlier, on net sales of $430 million (up 1%). For the first nine months, net income was flat at $140 million. Management updated 2025 guidance to $1.47 billion in sales (up 1%) and diluted EPS of $5.12 (flat versus 2024), citing slower-than-anticipated growth through September and softer demand in several international markets.
Q3 2025 net sales $430 million, up 1%; diluted EPS $2.05 vs. $1.93 a year earlier
Nine-month net sales $1.10 billion, up 1%; diluted EPS $4.36 vs. $4.34
Updated full-year 2025 guidance: $1.47 billion in sales and $5.12 diluted EPS; 2026 initial guidance due November 18, 2025
Quarterly dividend of $0.80 per share payable December 31, 2025, to holders of record December 15, 2025
Interparfums reported third-quarter 2025 net sales of $430 million, up 1% from $425 million a year earlier, and nine-month net sales of $1.102 billion, up 1% from $1.091 billion. The release covers sales only and does not include profit or earnings per share; the company will report full third-quarter results on November 5, 2025.
Q3 2025 net sales $430 million vs. $425 million in Q3 2024 (up 1%)
Nine-month 2025 net sales $1.102 billion vs. $1.091 billion (up 1%)
European-based sales rose 5% in Q3 to $295 million; US-based sales fell 6% to $137 million
Full third-quarter results due November 5, 2025; conference call November 6, 2025 at 11:00 am ET
Interparfums reported second-quarter 2025 net sales of $334 million, down 2% from a year earlier, with operating income down 9% to $59 million and diluted EPS of $0.99 versus $1.14. Management said second-quarter results were affected by trade destocking and reaffirmed full-year 2025 guidance of $1.51 billion in net sales and $5.35 diluted EPS. The company also declared a regular quarterly dividend of $0.80 per share.
Q2 net sales $334 million (down 2%); gross margin rose 170 basis points to 66.2%
Q2 operating income $59 million (down 9%); net income attributable to Interparfums $32 million (down 13%)
First-half net sales $673 million (up 1%); first-half diluted EPS $2.32 vs $2.41
2025 guidance reaffirmed at $1.51 billion net sales and $5.35 diluted EPS; $0.80 dividend payable September 30, 2025
Interparfums reported second-quarter 2025 net sales of $334 million, down 2% from $342 million a year earlier, while net sales for the six months ended June 30, 2025 rose 1% to $673 million. European based sales rose 6% in the quarter, but United States based sales fell 20%, which management attributed mainly to the discontinuation of the Dunhill license; full financial results are due August 5, 2025.
Q2 2025 net sales: $334 million, down 2% from $342 million in Q2 2024
Six months ended June 30, 2025 net sales: $673 million, up 1% from $666 million
European based net sales rose 6% to $241 million; United States based net sales fell 20% to $96 million
Full results for the three and six months ended June 30, 2025 to be released August 5, 2025; conference call August 6, 2025 at 11:00 am ET
Interparfums reported first-quarter 2025 net sales of $339 million, up 5%, and diluted earnings per share of $1.32, up 4% from $1.27 a year earlier. The company reaffirmed its 2025 guidance of $1.51 billion in net sales and $5.35 in diluted EPS, both up 4%, which signals management expects the year to track its original plan.
Operating income rose 10% to $75 million, and operating margin widened to 22.2% from 21.0%.
Gross margin improved to 63.7% from 62.5%, which the company attributed to favorable brand and channel mix.
Cash used in operating activities fell to $7 million from $52 million a year earlier.
The quarterly dividend is $0.80 per share, payable June 30, 2025, to shareholders of record on June 13, 2025.
Interparfums reported first-quarter 2025 net sales of $339 million, up 5% from $324 million a year earlier, and described the result as a record first quarter. The company reaffirmed its previously announced 2025 guidance of $1.51 billion in net sales and $5.35 in diluted earnings per share, and it will report full first-quarter results on May 5, 2025, with a conference call on May 6, 2025.
Net sales $339 million, up 5% from $324 million; European based sales $248 million (up 7%), United States based sales $94 million (down 1%)
United States based organic sales rose 3%, excluding the discontinued Dunhill license, which had a 4% negative impact
Montblanc fragrance sales declined 16% against a high prior-year base; the company expects sales to increase through the balance of 2025
2025 guidance reaffirmed: net sales of $1.51 billion and diluted EPS of $5.35, each a 4% increase; results due May 5, 2025, call May 6, 2025 at 11:00 am ET
Interparfums reported record fourth-quarter and full-year 2024 results, with full-year net sales up 10% to $1.45 billion and diluted EPS of $5.12, up from $4.75. The company reaffirmed its 2025 guidance and raised its annual cash dividend 7% to $3.20 per share, which shareholders should weigh alongside a $4 million impairment loss tied to Rochas Fashion.
Full-year 2024 net sales rose 10% to $1.45 billion; fourth-quarter net sales were $362 million, up 10%.
Full-year diluted EPS was $5.12, or $5.18 before the $4 million impairment loss, versus the $5.15 guidance the company had given.
2025 guidance calls for net sales of $1.51 billion and EPS of $5.35, both up 4%, and was reaffirmed.
Annual cash dividend rate increased to $3.20 from $3.00; next quarterly dividend of $0.80 is payable March 28, 2025, to holders of record on March 14, 2025.
Interparfums reported that fourth-quarter 2024 net sales rose 10% to $362 million and full-year net sales rose 10% to $1.45 billion, both versus 2023. The company said the sales goal positions it to meet its 2024 earnings per diluted share target of $5.15, excluding a non-cash trademark impairment of about $0.07 per diluted share, but it did not report profit figures in this filing. Full results and 2025 guidance are due February 25, 2025.
Q4 2024 net sales of $362 million, up 10% from $329 million in Q4 2023
Full-year 2024 net sales of $1.45 billion, up 10% from $1.32 billion in 2023
Company says sales goal positions it to meet 2024 EPS target of $5.15, excluding an impairment of about $0.07 per diluted share
Full 2024 results and 2025 guidance to be released February 25, 2025; conference call February 26, 2025
Interparfums reported third-quarter 2024 net sales of $425 million, up 15%, with operating income up 22% to $106 million and diluted EPS of $1.93 versus $1.66 a year earlier. The company reaffirmed its 2024 guidance of $1.45 billion in net sales and $5.15 diluted EPS, and said initial 2025 guidance will come on November 12, 2024.
Q3 2024 net sales were $425 million, up 15% from $368 million; nine-month net sales were $1.09 billion, up 10%.
Q3 diluted EPS was $1.93, up from $1.66; nine-month diluted EPS was $4.34, down 2% from $4.42.
Operating cash flow for Q3 was $76.1 million, compared with $17.5 million in the prior-year quarter.
The regular quarterly dividend of $0.75 per share is payable December 31, 2024, to holders of record on December 16, 2024.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Inter Parfums filing is on SEC EDGAR ↗. 8-K briefs of other companies →